Last quarter (Q3 2020), Primo Nutraceuticals's total revenue was C$―, a decrease of ― from the same quarter last year. In Q3, Primo Nutraceuticals's net income was C$-390.38K. See Primo Nutraceuticals’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Jul 19	Jul 18	Jul 17	Jul 16
Total Revenue	-	-	-	C$ 0.00	C$ 0.00
Cost of Revenue	-	-	-	-	-
Gross Profit	-	-	-	-	-
Operating Expense	C$ 1.50M	C$ 1.40M	C$ 748.56K	C$ 51.18K	C$ 47.24K
Operating Income	C$ -1.50M	C$ -1.40M	C$ -748.56K	C$ -51.18K	C$ -47.24K
Net Non Operating Interest Income Expense	C$ -669.00	C$ 2.50K	C$ 1.74K	C$ 0.00	-
Other Income Expense	C$ -2.34M	C$ -3.72M	C$ -33.31K	C$ -3.65K	-
Pretax Income	C$ -3.84M	C$ -5.13M	C$ -783.61K	C$ -54.82K	C$ -47.24K
Tax Provision	-	-	-	-	-
Earnings From Equity Interest Net Of Tax	-	-	-	-	-
Net Income Common Stockholders	C$ -3.84M	C$ -5.13M	C$ -783.61K	C$ -54.82K	C$ -47.24K
Basic EPS	C$ -1.50	C$ -18.00	C$ -3.45	C$ -0.02	C$ -0.01
Diluted EPS	C$ -1.50	C$ -18.00	C$ -3.45	C$ -0.02	C$ -0.01
Basic Average Shares	C$ 12.94M	C$ 291.95K	C$ 227.43K	C$ 3.41M	C$ 3.41M
Diluted Average Shares	C$ 12.94M	C$ 291.95K	C$ 227.43K	C$ 3.41M	C$ 3.41M
Dividend Per Share	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-
Rent Expense Supplemental	C$ 7.49K	-	-	C$ 0.00	C$ 6.00K
Total Expenses	C$ 872.55K	C$ -1.40M	C$ -748.56K	C$ 51.18K	C$ 47.24K
Net Income From Continuing And Discontinued Operation	C$ -3.84M	C$ -5.13M	C$ -783.61K	C$ -54.82K	C$ -47.24K
Normalized Income	C$ -1.41M	C$ -211.84K	C$ -575.95K	C$ -51.18K	C$ -47.24K
Interest Expense	-	-	-	-	-
EBIT	C$ -1.66M	C$ -5.13M	C$ -783.61K	C$ -51.18K	C$ -47.24K
EBITDA	C$ -1.66M	C$ -5.13M	C$ -783.61K	C$ -51.18K	C$ -47.24K

Currency in CAD

Primo Nutraceuticals Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing